Zobrazit v EDS

Antiviral drug discovery: preparing for the next pandemic

Uloženo v:
Podrobná bibliografie
Název: Antiviral drug discovery: preparing for the next pandemic
Autoři: Adamson, Catherine S., Chibale, Kelly, Goss, Rebecca J. M., Jaspars, Marcel, Newman, David J., Dorrington, Rosemary A.
Přispěvatelé: Medical Research Council, University of St Andrews.School of Biology, University of St Andrews.Biomedical Sciences Research Complex, University of St Andrews.EaSTCHEM, University of St Andrews.School of Chemistry, University of Aberdeen.The Marine Biodiscovery Centre, University of Aberdeen.Marine Alliance for Science and Technology for Scotland (MASTS), University of Aberdeen.Chemistry
Zdroj: Chemical Society Reviews
Informace o vydavateli: Royal Society of Chemistry (RSC), 2021.
Rok vydání: 2021
Témata: 0301 basic medicine, Small Molecule Libraries/chemistry, Antiviral Agents/chemistry, SARS-CoV-2/chemistry, COVID-19/drug therapy, Antiviral Agents, Small Molecule Libraries, 03 medical and health sciences, SDG 3 - Good Health and Well-being, RA0421, RA0421 Public health. Hygiene. Preventive Medicine, Drug Discovery, Humans, QD, Drug Discovery/methods, Molecular Targeted Therapy, Pandemics/prevention & control, Pandemics, CVG-1725-2020, Nucleic Acid Synthesis Inhibitors, QR355, Biological Products, 0303 health sciences, Biological Products/chemistry, SARS-CoV-2, COVID-19, General Chemistry, QD Chemistry, Medical Research Council (MRC), MR/Vo28464/1, COVID-19 Drug Treatment, 3. Good health, Molecular Docking Simulation, Coronavirus Protease Inhibitors, Nucleic Acid Synthesis Inhibitors/chemistry, RNA, RNA, Viral, Other, QR355 Virology, Coronavirus Protease Inhibitors/chemistry, Molecular Targeted Therapy/methods, Viral/antagonists & inhibitors
Popis: SARS-CoV-2, EBOV and emerging RNA viruses are amongst the most important global health threats; yet clinically approved antiviral drugs are available for only 10 of the more than 220 viruses known to infect humans.
Druh dokumentu: Article
Popis souboru: pdf; application/pdf
Jazyk: English
ISSN: 1460-4744
0306-0012
DOI: 10.1039/d0cs01118e
Přístupová URL adresa: https://pubs.rsc.org/en/content/articlepdf/2021/cs/d0cs01118e
https://pubmed.ncbi.nlm.nih.gov/33524090
https://research-repository.st-andrews.ac.uk/bitstream/10023/21355/1/Adamson_2021_Antiviral_drug_discovery_ChemSocRev_CC.pdf
https://pubs.rsc.org/en/content/articlelanding/2021/cs/d0cs01118e#!
https://research-repository.st-andrews.ac.uk/handle/10023/21355
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=202102284968928785
https://pubs.rsc.org/en/content/articlepdf/2021/cs/d0cs01118e
https://covid19.elsevierpure.com/en/publications/antiviral-drug-discovery-preparing-for-the-next-pandemic
Rights: CC BY NC
Přístupové číslo: edsair.doi.dedup.....06f739a24eb346942d01c371b5aa3249
Databáze: OpenAIRE
Popis
Abstrakt:SARS-CoV-2, EBOV and emerging RNA viruses are amongst the most important global health threats; yet clinically approved antiviral drugs are available for only 10 of the more than 220 viruses known to infect humans.
ISSN:14604744
03060012
DOI:10.1039/d0cs01118e